Epigral has informed that pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the Company will be held on Monday, 5th May, 2025, at the Registered Office of the Company, to consider Audited Financial Results (Standalone & Consolidated) of the Company for the Fourth Quarter and Year ended on 31st March, 2025 and to take on record the Report of the Statutory Auditors thereon; and recommendation of Final Dividend, if any, on the Equity Shares of Rs 10 each of the Company for Financial Year ended 31st March, 2025; and any other business with the permission of the Chair.
The above information is a part of company’s filings submitted to BSE.
